Nucleic acid-mediated inflammatory diseases.

Area of Science:

• Biochemistry
• Immunology
• Genetics

Background:

• Nucleic acid-degrading enzymes are increasingly recognized for their role in inflammatory disease pathogenesis.
• Aicardi-Goutières syndrome (AGS), a childhood inflammatory neurological disorder, is caused by mutations in four specific genes.
• AGS shares clinical and immunological features with congenital viral infections.

Purpose of the Study:

• To investigate the role of nucleic acid-degrading enzymes in inflammatory disease.
• To understand the molecular mechanisms underlying Aicardi-Goutières syndrome.
• To explore the link between enzyme function, nucleic acid metabolism, and innate immune activation.

Main Methods:

• Genetic analysis to identify causative genes for AGS.
• Biochemical characterization of nucleases TREX1 and Ribonuclease H2 (RNase H2) complex.
• Hypothesis generation based on observed enzyme mutations and disease phenotypes.

Main Results:

• Four genes causing AGS were identified, encoding TREX1 and the RNase H2 complex.
• Mutations in these enzymes, previously characterized biochemically, were linked to a neurological inflammatory disorder.
• This finding challenges prior understanding of these enzymes' functions.

Conclusions:

• Mutations in nucleic acid-degrading enzymes TREX1 and RNase H2 are implicated in Aicardi-Goutières syndrome.
• A hypothesis suggests that impaired nucleic acid degradation leads to intracellular nucleic acid accumulation.
• This accumulation may trigger innate immune pattern recognition receptors, driving inflammatory responses in AGS.